These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38798630)

  • 1. All-in-one AAV-delivered epigenome-editing platform:
    Kantor B; Odonovan B; Rittiner J; Hodgson D; Lindner N; Guerrero S; Dong W; Zhang A; Chiba-Falek O
    bioRxiv; 2024 May; ():. PubMed ID: 38798630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders.
    Kantor B; O'Donovan B; Rittiner J; Hodgson D; Lindner N; Guerrero S; Dong W; Zhang A; Chiba-Falek O
    Nat Commun; 2024 Aug; 15(1):7259. PubMed ID: 39179542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA.
    Woodward EA; Wang E; Wallis C; Sharma R; Tie AWJ; Murthy N; Blancafort P
    Methods Mol Biol; 2024; 2842():267-287. PubMed ID: 39012601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic
    Himeda CL; Jones TI; Jones PL
    Mol Ther Methods Clin Dev; 2021 Mar; 20():298-311. PubMed ID: 33511244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
    Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
    BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic immunomodulation with a CRISPR super-repressor in vivo.
    Moghadam F; LeGraw R; Velazquez JJ; Yeo NC; Xu C; Park J; Chavez A; Ebrahimkhani MR; Kiani S
    Nat Cell Biol; 2020 Sep; 22(9):1143-1154. PubMed ID: 32884147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/dCas9-Mediated Gene Silencing in Two Plant Fungal Pathogens.
    Zhang YM; Zheng L; Xie K
    mSphere; 2023 Feb; 8(1):e0059422. PubMed ID: 36655998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
    Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
    Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Mini-Cas9 for Transcriptional Activation.
    Ma D; Peng S; Huang W; Cai Z; Xie Z
    ACS Synth Biol; 2018 Apr; 7(4):978-985. PubMed ID: 29562138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
    Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
    Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
    Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
    Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
    Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
    Fry LE; Peddle CF; Stevanovic M; Barnard AR; McClements ME; MacLaren RE
    CRISPR J; 2020 Aug; 3(4):276-283. PubMed ID: 32833533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Systems Suitable for Single AAV Vector Delivery.
    Stevanovic M; Piotter E; McClements ME; MacLaren RE
    Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
    Lowder LG; Paul JW; Qi Y
    Methods Mol Biol; 2017; 1629():167-184. PubMed ID: 28623586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.
    Thakore PI; D'Ippolito AM; Song L; Safi A; Shivakumar NK; Kabadi AM; Reddy TE; Crawford GE; Gersbach CA
    Nat Methods; 2015 Dec; 12(12):1143-9. PubMed ID: 26501517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
    Goubert D; Koncz M; Kiss A; Rots MG
    Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.